27 reports

  • Austria healthcare providers sector category segmentation: $ billion, 2019
  • Austria healthcare providers sector category segmentation: % share, by value, 2019

Table ##: Austria healthcare providers sector value: $ billion, 2015-## Figure ##: Austria healthcare providers sector value: $ billion, 2015-## ##.

  • Health Care Provider
  • Healthcare
  • Austria
  • Market Size
  • ORPEA group
  • Healthcare Expenditure, Austria
  • The Austrian Healthcare Policy Highlights

Pfizer' s Consumer Healthcare business is one of the world' s largest branded multinational OTC consumer healthcare businesses.

  • Healthcare
  • Medical Device
  • Medical Equipment
  • Pharmaceutical
  • Austria

It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies.

  • Healthcare
  • Pharmaceutical
  • Austria
  • Demand
  • Market Size
  • ICT MARKET OPPORTUNITY IN THE HEALTH CARE SECTOR BY VALUE, USD MILLION, 2016 - 2019
  • ICT MARKET OPPORTUNITY IN THE HEALTH CARE SECTOR BY CATEGORY, USD MILLION, 2016 - 2019

Within the body of this report Kable present the market size and forecast spending trends for the sector which covers: TABLE ##: CATEGORY DEFINITIONS Domain Category Definition cards are now almost always built into PCs as a standard.

  • Healthcare
  • ICT
  • Austria
  • Market Segment
  • Market Size
  • Health Insurance - NEP (EUR Million)
  • AUSTRIAN HEALTH INSURANCE - BUSINESS PERFORMANCE

Health insurance: ##%.

  • Healthcare
  • Austria
  • Market Shares
  • UNIQA Group
  • Vienna Insurance Group
  • Passport 3
  • International Manufacturers Continue To Dominate Wound Care

Austria has a large number of reimbursable OTC healthcare medicines.

  • Healthcare
  • OTC
  • Wound Care
  • Austria
  • Demand
  • AOP Orphan Pharma Forms Joint Venture with Rigi Healthcare
  • Apr 12, 2017: AOP Orphan Appoints Miroslaw Jan Lubecki as Chief of Commercial Operations

GlobalData Aop Orphan Pharmaceuticals AG' s, deal volume increased from zero pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • Pharmaceutical
  • Austria
  • Company
  • AOP Orphan Pharmaceuticals AG
  • HEALTHCARE
  • PARALLEL TRADE

The 2013 healthcare reform law (signed into law in April 2013 and effective retrospectively from ## January 2013) provides for the development of the DMP scheme to cover additional chronic conditions.

  • Health Insurance
  • Healthcare
  • Hospital
  • Pharmacy
  • Austria

The company' s deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Healthcare
  • Therapy
  • Vaccine
  • Austria
  • Themis Bioscience GmbH

The company' s deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Healthcare
  • Therapy
  • Vaccine
  • Austria
  • Themis Bioscience GmbH

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Austria

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Austria
  • Biomay AG, Pharmaceuticals & Healthcare, Deal Details

GlobalData Biomay AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 Deal Type Equity Offerings Licensing Agreement No. of Deals ## ## Deal Value (US$ million) ##. ## NA Biomay AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 Biomay AG,

  • Allergy
  • Chronic Disease
  • Austria
  • Deals & Alliance
  • Biomay AG

The company' s deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Healthcare
  • Pharmaceutical
  • Austria
  • Deals & Alliance
  • CROMA-PHARMA GmbH
  • APEIRON Biologics AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

GlobalData Deal Type Licensing Agreement Partnerships Divestiture - Assets No. of Deals ## ## ## Deal Value (US$ million) NA ##. ## NA APEIRON Biologics AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 APEIRON Biologics AG, Pharmaceuticals &

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Austria
  • Apeiron Biologics AG

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Austria
  • QPS AUSTRIA GMBH, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS
  • QPS AUSTRIA GMBH, MEDICAL DEVICES DEALS, 2012 TO YTD 2018

GlobalData Deal Type Acquisition Licensing Agreement Partnerships No. of Deals ## ## ## Deal Value (US$ million) NA NA NA QPS AUSTRIA GMBH, PHARMACEUTICALS & HEALTHCARE, DEALS BY REGION, 2012 TO YTD 2018 QPS AUSTRIA GMBH, PHARMACEUTICALS &

  • Healthcare
  • Mental Health
  • Pharmaceutical
  • Austria
  • Deals & Alliance
  • BIOVENDOR - LABORATORNI MEDICINA AS, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS
  • BIOVENDOR - LABORATORNI MEDICINA AS, PHARMACEUTICALS & HEALTHCARE, DEALS SUMMARY, 2012 TO YTD 2018

GlobalData BioVendor - Laboratorni Medicina as' s, deal volume increased from one pharmaceuticals & healthcare deal in 2016 to two pharmaceuticals & healthcare deals in 2017.

  • Diagnostics
  • Healthcare
  • Austria
  • Deals & Alliance
  • Cyxone AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

GlobalData Cyxone AB reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Healthcare
  • Pharmaceutical
  • Austria
  • Company
  • Bachem Holding AG
  • MEDICAL UNIVERSITY OF VIENNA, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS
  • Medical University of Vienna, Deals By Therapy Area, 2012 to YTD 2018

The company' s deal volume decreased from two pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • Austria

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Austria
  • Cyxone AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

GlobalData Cyxone AB reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Healthcare
  • Pharmaceutical
  • Austria
  • Company
  • Bachem Holding AG
  • AFFIRIS AG, PHARMACEUTICALS & HEALTHCARE, DEALS SUMMARY, 2011 TO YTD 2017
  • AFFIRIS EXTENDS LICENSING AGREEMENT WITH GLAXOSMITHKLINE

GlobalData AFFiRiS AG, reported one pharmaceuticals & healthcare deal each in 2015 and 2016.

  • Healthcare
  • Austria
  • Corporate Finance
  • Deals & Alliance
  • AFFiRiS AG

The molecules developed by companies in Phase II, Phase I and Preclinical stages are ##, ## and ## respectively.

  • Healthcare
  • Therapy
  • Vaccine
  • Austria
  • Papivax, Llc

The molecules developed by companies in Phase II, Phase I and Preclinical stages are ##, ## and ## respectively.

  • Healthcare
  • Therapy
  • Vaccine
  • Austria
  • Papivax, Llc
  • Miracor Medical Systems Raises Additional USD7.6 Million in Series C Financing
  • VENTURE FINANCING

The firm' s services include fund management, portfolio management, healthcare, and medtech services.

  • Healthcare
  • Medical Device
  • Medical Supply
  • Austria
  • Deals & Alliance

GlobalData offers comprehensive geographic coverage across world' s most important sectors, focusing particularly on energy and healthcare.

  • Healthcare
  • Medical Device
  • Medical Equipment
  • Austria
  • AIT Austrian Institute of Technology GmbH